Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
N Engl J Med. 2015 Jun 18;372252387-97. doi 10.1056/NEJMoa1410489. Epub 2015 Jun 3. Ezetimibe Added to Statin Therapy after Acute Coronary. May 18, 2016. According to a paper being published in the New England Journal of. NPC1L1, is the target of another marketed drug, Zetia, from Merck. Feb 26, 2014. Ezetimibe was introduced as Zetia in October 2002 and in combination with simvastatin Vytorin in July 2004 in the US. N Engl J Med. 2008.
Impact of the ENHANCE Trial on the Use of Ezetimibe in the United.
Jun 4, 2015. showed a clinical benefit to adding ezetimibe Zetia, Merck/Schering. The study is published June 3, 2015 in the New England Journal of. Today announced that the New England Journal of Medicine published the. VYTORIN and ZETIA are currently indicated for use along with a healthy diet to.
Simvastatin/Ezetimibe, a Lipid-Lowering Combination Pill, Might Be.
Jan 30, 2015. Simvastatin/Ezetimibe, a Lipid-Lowering Combination Pill, Might Be Effective for Alopecia Areata - NEJM Journal Watch. Dec 14, 2015. for the use of VYTORIN® ezetimibe/simvastatin and ZETIA® ezetimibe the latter.